BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21920464)

  • 1. Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer.
    Eyking A; Ey B; Rünzi M; Roig AI; Reis H; Schmid KW; Gerken G; Podolsky DK; Cario E
    Gastroenterology; 2011 Dec; 141(6):2154-65. PubMed ID: 21920464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal Cancer.
    Eyking A; Reis H; Frank M; Gerken G; Schmid KW; Cario E
    PLoS One; 2016; 11(6):e0156871. PubMed ID: 27271572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinoic Acid Facilitates Toll-Like Receptor 4 Expression to Improve Intestinal Barrier Function through Retinoic Acid Receptor Beta.
    Li Y; Gao Y; Cui T; Yang T; Liu L; Li T; Chen J
    Cell Physiol Biochem; 2017; 42(4):1390-1406. PubMed ID: 28715808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Colon Tumors Express a Dominant-Negative Form of SIGIRR That Promotes Inflammation and Colitis-Associated Colon Cancer in Mice.
    Zhao J; Bulek K; Gulen MF; Zepp JA; Karagkounis G; Martin BN; Zhou H; Yu M; Liu X; Huang E; Fox PL; Kalady MF; Markowitz SD; Li X
    Gastroenterology; 2015 Dec; 149(7):1860-1871.e8. PubMed ID: 26344057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis.
    Omrane I; Baroudi O; Kourda N; Bignon YJ; Uhrhammer N; Desrichard A; Medimegh I; Ayari H; Stambouli N; Mezlini A; Bouzayenne H; Marrakchi R; Benammar-Elgaaid A; Bougatef K
    Tumour Biol; 2014 Jan; 35(1):545-51. PubMed ID: 23949880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis.
    Fukata M; Shang L; Santaolalla R; Sotolongo J; Pastorini C; España C; Ungaro R; Harpaz N; Cooper HS; Elson G; Kosco-Vilbois M; Zaias J; Perez MT; Mayer L; Vamadevan AS; Lira SA; Abreu MT
    Inflamm Bowel Dis; 2011 Jul; 17(7):1464-73. PubMed ID: 21674704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of claudin-3 expression induces IL6/gp130/Stat3 signaling to promote colon cancer malignancy by hyperactivating Wnt/β-catenin signaling.
    Ahmad R; Kumar B; Chen Z; Chen X; Müller D; Lele SM; Washington MK; Batra SK; Dhawan P; Singh AB
    Oncogene; 2017 Nov; 36(47):6592-6604. PubMed ID: 28783170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium.
    Naik S; Kelly EJ; Meijer L; Pettersson S; Sanderson IR
    J Pediatr Gastroenterol Nutr; 2001 Apr; 32(4):449-53. PubMed ID: 11396812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-32θ inhibits stemness and epithelial-mesenchymal transition of cancer stem cells via the STAT3 pathway in colon cancer.
    Bak Y; Kwon T; Bak IS; Hong J; Yu DY; Yoon DY
    Oncotarget; 2016 Feb; 7(6):7307-17. PubMed ID: 26824417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration.
    Phesse TJ; Buchert M; Stuart E; Flanagan DJ; Faux M; Afshar-Sterle S; Walker F; Zhang HH; Nowell CJ; Jorissen R; Tan CW; Hirokawa Y; Eissmann MF; Poh AR; Malaterre J; Pearson HB; Kirsch DG; Provero P; Poli V; Ramsay RG; Sieber O; Burgess AW; Huszar D; Vincan E; Ernst M
    Sci Signal; 2014 Sep; 7(345):ra92. PubMed ID: 25270258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human TLR4 polymorphism D299G/T399I alters TLR4/MD-2 conformation and response to a weak ligand monophosphoryl lipid A.
    Yamakawa N; Ohto U; Akashi-Takamura S; Takahashi K; Saitoh S; Tanimura N; Suganami T; Ogawa Y; Shibata T; Shimizu T; Miyake K
    Int Immunol; 2013 Jan; 25(1):45-52. PubMed ID: 22962435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice.
    Tsoi H; Chu ESH; Zhang X; Sheng J; Nakatsu G; Ng SC; Chan AWH; Chan FKL; Sung JJY; Yu J
    Gastroenterology; 2017 May; 152(6):1419-1433.e5. PubMed ID: 28126350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas.
    Grade M; Hörmann P; Becker S; Hummon AB; Wangsa D; Varma S; Simon R; Liersch T; Becker H; Difilippantonio MJ; Ghadimi BM; Ried T
    Cancer Res; 2007 Jan; 67(1):41-56. PubMed ID: 17210682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TLR4 D299G and T399I SNPs are constitutively active to up-regulate expression of Trif-dependent genes.
    Hold GL; Berry S; Saunders KA; Drew J; Mayer C; Brookes H; Gay NJ; El-Omar EM; Bryant CE
    PLoS One; 2014; 9(11):e111460. PubMed ID: 25365308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide.
    Abreu MT; Vora P; Faure E; Thomas LS; Arnold ET; Arditi M
    J Immunol; 2001 Aug; 167(3):1609-16. PubMed ID: 11466383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy of Intestinal Epithelial Cells Inhibits Colorectal Carcinogenesis Induced by Colibactin-Producing Escherichia coli in Apc
    Lucas C; Salesse L; Hoang MHT; Bonnet M; Sauvanet P; Larabi A; Godfraind C; Gagnière J; Pezet D; Rosenstiel P; Barnich N; Bonnet R; Dalmasso G; Nguyen HTT
    Gastroenterology; 2020 Apr; 158(5):1373-1388. PubMed ID: 31917256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
    Campbell-Thompson M; Lynch IJ; Bhardwaj B
    Cancer Res; 2001 Jan; 61(2):632-40. PubMed ID: 11212261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The D299G/T399I Toll-like receptor 4 variant associates with body and liver fat: results from the TULIP and METSIM Studies.
    Weyrich P; Staiger H; Stančáková A; Machicao F; Machann J; Schick F; Stefan N; Kuusisto J; Laakso M; Schäfer S; Fritsche A; Häring HU
    PLoS One; 2010 Nov; 5(11):e13980. PubMed ID: 21125016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of functional D299G.T399I polymorphic variant of TLR4 depends more on coexpression of MD-2 than does wild-type TLR4.
    Prohinar P; Rallabhandi P; Weiss JP; Gioannini TL
    J Immunol; 2010 Apr; 184(8):4362-7. PubMed ID: 20212095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4 D299G polymorphism modulates cytokine expression in ulcerative colitis.
    Meena NK; Verma R; Verma N; Ahuja V; Paul J
    J Clin Gastroenterol; 2013 Oct; 47(9):773-80. PubMed ID: 23470644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.